论文部分内容阅读
亚临床甲减是妊娠期妇女的中的常见病[1],其主要诊断为血清化验指标中的TSH超过正常值的上限,但是FT3和FT4的生化指标在正常范围之内。导致这种情况的原因,其具体的致病机制尚无明确定论,多数学者认为是自身免疫性的甲状腺病变。目前临床上多采用左甲状腺素钠片(优甲乐)治疗亚临床甲减,该药物可有效调节患者体内的TSH的水平,维持甲状腺的正常功能[2]。笔者近年来收入132名孕妇的孕检信息,采用优甲乐对妊娠期亚临床甲状腺功能减退的孕妇进行治疗,取得满意疗效,具体情况回顾统计分析,撰写文章如下:
Subclinical hypothyroidism is a common disease in pregnant women [1], the main diagnosis of the serum test indicators TSH exceeds the upper limit of normal, but FT3 and FT4 biochemical indicators within the normal range. The cause of this situation, the specific pathogenic mechanism is not conclusive, most scholars believe that autoimmune thyroid disease. At present, the clinical use of levothyroxine sodium tablets (Euthyrox) treatment of subclinical hypothyroidism, the drug can effectively regulate the level of TSH in patients with the body to maintain the normal thyroid function [2]. In recent years, the author has received information on the pregnancy test of 132 pregnant women, treated with Euthyrox on pregnant women with subclinical hypothyroidism during pregnancy and obtained satisfactory curative effect. According to the statistical analysis, the author writes the following articles: